The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
about
Lifestyle and dietary factors in the prevention of lethal prostate cancerCoumaphos exposure and incident cancer among male participants in the Agricultural Health Study (AHS)Sex Steroid Hormone Single-Nucleotide Polymorphisms, Pesticide Use, and the Risk of Prostate Cancer: A Nested Case-Control Study within the Agricultural Health StudyOrganophosphate insecticide use and cancer incidence among spouses of pesticide applicators in the Agricultural Health StudyPerinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesisDifferential effects of selenium on benign and malignant prostate epithelial cells: stimulation of LNCaP cell growth by noncytotoxic, low selenite concentrations.A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review).Association between C-peptide concentration and prostate cancer incidence in the CLUE II cohort study.Clarifying the positive association between education and prostate cancer: a Monte Carlo simulation approach.Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men.Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis.Sex steroid hormone metabolism in relation to risk of aggressive prostate cancerToremifene--a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapy.Fatherhood and incident prostate cancer in a prospective US cohort.Associations between longitudinal changes in serum estrogen, testosterone, and bioavailable testosterone and changes in benign urologic outcomesMetabolic imbalance and prostate cancer progression.The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population.Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study.Coffee consumption and urologic cancer risk: a meta-analysis of cohort studies.Total testosterone in young men is more closely associated than free testosterone with prostate cancer disparitiesXenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer.Non steroidal anti-inflammatory drug use and levels of oestrogens and androgens in men.Oral contraceptive use is associated with prostate cancer: an ecological study.Hormones and prostate carcinogenesis: Androgens and estrogens.Dietary acrylamide and risk of prostate cancer.Developmental estrogen exposures predispose to prostate carcinogenesis with aging.Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and ProstateSRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.Assay reproducibility of serum androgen measurements using liquid chromatography-tandem mass spectrometry.A cross-sectional study of the association of age, race and ethnicity, and body mass index with sex steroid hormone marker profiles among men in the National Health and Nutrition Examination Survey (NHANES III)The role of estrogens and estrogen receptors in normal prostate growth and disease.Do evolutionary life-history trade-offs influence prostate cancer risk? a review of population variation in testosterone levels and prostate cancer disparities.Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case-control series of veteransTea beverage in chemoprevention and chemotherapy of prostate cancer.Association between endogenous sex steroid hormones and inflammatory biomarkers in US menProstate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments.Association between dietary phytoestrogens intakes and prostate cancer risk in Sicily.Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy resultRacial Differences in Age-Related Variations of Testosterone Levels Among US Males: Potential Implications for Prostate Cancer and Personalized Medication.Bayesian logistic regression in detection of gene-steroid interaction for cancer at PDLIM5 locus.
P2860
Q27025735-48BC0117-8E9A-4415-9B3D-CEF65BC698FBQ28394004-8E8B36B0-C64D-4564-BFA3-8B199017ED0CQ28394503-C1DB49A6-A830-43F8-94AD-AEC9E53B1276Q28397029-03FE2E75-8F4D-48BE-B8D3-2E82994C55C8Q33642456-A64E7B9E-20B5-4BAE-A60F-1B6341518B4FQ33652577-568CD490-9762-4007-8ABC-5574268EDD3BQ34141355-0BF22661-1032-426C-B653-D3030DCCAE82Q34203868-B309F56E-C53D-448F-A689-616A8B25E7A5Q34345432-E693EA2E-3EDD-4ABF-B0AB-F9163703F0BEQ34415727-07A90C63-B090-44B6-89A9-9C370A994912Q34434293-B7EE7E40-3737-40D3-A588-6DFACEAEFEDFQ34458421-547477A2-CA41-4191-99A2-E7F82310BB4FQ34497901-2B5AC976-EC40-4B84-9C8E-EF765FC8C5DBQ34734149-9958F30B-0C2B-4991-AA22-C51FB3737CC7Q34760359-CA6A6E8A-FCCF-4BC6-9CCF-4E9BF74B7F1EQ34794028-840D86AB-2C8A-4C2B-BFB4-600A3EB36D27Q34962430-435FD5A9-F95B-48F7-B054-0593F808F66AQ35031408-EA367D07-91A0-438E-A2A2-7797613D7F7DQ35133994-8326AC79-345E-4B8B-9FD6-F5A17ADB522CQ35174480-A4D6E373-8F8E-4016-8908-676F3DA3CD1CQ35211213-5D9AEF8D-860E-4C4C-ABDB-20361342D670Q35560665-919C482F-6898-4245-9585-B90D4354CCDCQ35564878-1FD9855B-39FF-4960-BD7A-51BCB4B3916DQ35687198-C6203D3C-D77D-4E1C-9929-A0536B18439AQ35873768-E6E3ACC1-B35E-4A05-A519-3F314EEE39DDQ35903630-011ABBA6-089D-4F78-8835-3E4FED35044CQ36077025-9C174419-A3C3-49CB-9EF6-BCA9B04F11B1Q36254416-75D3E3A9-D47D-46B4-8F1B-3B2D4BCA3368Q36328373-91787C04-AA6F-417A-B3BD-FDEE4DE92DECQ36370472-537ED4E0-10BA-4F08-9A97-0B5938251D9EQ36488068-572DD6AB-B3B3-46F5-884B-69DC78648A29Q36595774-7179ACF9-B58B-4E7D-94D1-64F0C593489BQ36806907-605684F4-527B-4078-86B4-6CD02236E48BQ36920776-6340D12B-B0D6-4D64-90C7-236D1509F697Q37265941-B15604BB-0627-43D6-99D3-2F3F149B1B08Q38177161-9BB68F61-9C0D-44AB-9359-B88D6A5CF768Q38620085-66BBF9AD-C742-47B7-9435-DE566C7399D8Q39483117-5572E8E6-E8DC-40B9-80C4-DB709403B0F0Q40008016-B157AEE7-094A-4A37-8436-EE23A7C495E7Q40678971-FE9B38C2-E680-44D6-9D95-08DB1F76E077
P2860
The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
The epidemiology of sex steroi ...... e etiology of prostate cancer.
@ast
The epidemiology of sex steroi ...... e etiology of prostate cancer.
@en
type
label
The epidemiology of sex steroi ...... e etiology of prostate cancer.
@ast
The epidemiology of sex steroi ...... e etiology of prostate cancer.
@en
prefLabel
The epidemiology of sex steroi ...... e etiology of prostate cancer.
@ast
The epidemiology of sex steroi ...... e etiology of prostate cancer.
@en
P1476
The epidemiology of sex steroi ...... e etiology of prostate cancer.
@en
P2093
Elizabeth A Platz
P304
P356
10.1016/J.JSBMB.2004.10.002
P577
2004-11-01T00:00:00Z